AYTU
Aytu BioPharma Inc.
NASDAQ · Healthcare
| Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Aug 2013 | Aug 2012 | Aug 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||
| Capital Expenditures | 228,000 | 329,000 | — | — | — | 0 | 59,848 | 74,707 | 111,608 | — | — | — |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||
| Free Cash Flow | -2.2M | -1.7M | — | — | — | -28.4M | -13.9M | -16.0M | -13.9M | — | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — |